Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.
Schuelke MR, Bassiri H, Behrens EM, Canna S, Croy C, DiNofia A, Gollomp K, Grupp S, Lambert M, Lambrix A, Maude SL, Myers R, Newman H, Petrosa W, Seif A, Sullivan KE, Teachey DT, Diorio C.
Schuelke MR, et al.
Blood Adv. 2023 Sep 26;7(18):5603-5607. doi: 10.1182/bloodadvances.2023010712.
Blood Adv. 2023.
PMID: 37721859
Free PMC article.
No abstract available.